Cairo-Mubasher: The Holding Company for Pharmaceuticals and Chemicals (HoldiPharma) said the combined earnings of 11 subsidiaries for the fiscal year 2014/2015 increased by 1.5% to EGP 331 million, compared with EGP 326 million a year earlier.
Total operating revenues reached EGP 9.7 billion in 2014/2015, compared with EGP 9 billion a year earlier.
The investments carried out by the subsidiaries amounted to EGP 131 million, compared with EGP 145 million in 2013/2014.
Total exports increased to EGP 234 million from EGP 217 million.
